867 — China Medical System Holdings Share Price
0.000.00%
Last trade - 00:00- HK$17.93bn
- HK$12.71bn
- CNY7.47bn
- 95
- 65
- 48
- 82
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 9.61 | ||
| PEG Ratio (f) | 2.63 | ||
| EPS Growth (f) | 3.79% | ||
| Dividend Yield (f) | 4.41% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.03 | ||
| Price to Tang. Book | 1.35 | ||
| Price to Free Cashflow | 20.75 | ||
| Price to Sales | 2.26 | ||
| EV to EBITDA | 6.34 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.33% | ||
| Return on Equity | 10.18% | ||
| Operating Margin | 22.86% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 6,945.96 | 8,337.22 | 9,150.35 | 8,013.28 | 7,468.99 | 8,292.39 | 9,626.53 | 4.22% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +39.6 | +11.07 | +9.78 | -22.07 | -33.42 | -3.51 | +20.86 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and sales of drugs. The Company's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The Company distributes its products within domestic market and to overseas markets.
Directors
- Kong Lam CHM (56)
- Yanling Chen CFO (50)
- Hongbing Chen COO (54)
- Sanyan Wu SEC (39)
- Ching Fung NID (52)
- Chong Shun Leung NID (55)
- Laura Ying Luo NID (55)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 18th, 2006
- Public Since
- September 28th, 2010
- No. of Employees
- 6,141
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 2,439,529,000
- Address
- Unit 2106, 21/F, Island Place Tower, 510
- Web
- https://web.cms.net.cn/zh/home/
- Phone
- +86 75582416868
- Auditors
- Deloitte Touche Tohmatsu
Upcoming Events for 867
Dividend For 0867.HK - 0.1270 HKD
China Medical System Holdings Ltd Annual Shareholders Meeting
Half Year 2025 China Medical System Holdings Ltd Earnings Release
Similar to 867
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the China Medical System Holdings share price?
As of Today at 19:59 UTC, shares in China Medical System Holdings are trading at HK$7.35. This share price information is delayed by 15 minutes.
How has the China Medical System Holdings share price performed this year?
Shares in China Medical System Holdings last closed at HK$7.35 and the price had moved by +4.26% over the past 365 days. In terms of relative price strength the China Medical System Holdings share price has outperformed the FTSE Developed Asia Pacific Index by +7.22% over the past year.
What are the analyst and broker recommendations for China Medical System Holdings?
The overall consensus recommendation for China Medical System Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the China Medical System Holdings dividend yield?
The China Medical System Holdings dividend yield is 3.96% based on the trailing twelve month period.
Does China Medical System Holdings pay a dividend?
Last year, China Medical System Holdings paid a total dividend of CNY0.27, and it currently has a trailing dividend yield of 3.96%.Looking ahead, shares in China Medical System Holdings are due to go ex-dividend on 2025-04-28 and the next dividend pay date is 2025-05-09.
When does China Medical System Holdings next pay dividends?
China Medical System Holdings are due to go ex-dividend on 2025-04-28 and the next dividend pay date is 2025-05-09. The historic dividend yield on China Medical System Holdings shares is currently 3.96%.
How do I buy China Medical System Holdings shares?
To buy shares in China Medical System Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of China Medical System Holdings?
As of the previous close price of HK$7.35, shares in China Medical System Holdings had a market capitalisation of HK$17.93bn.
Where are China Medical System Holdings shares listed?
Here are the trading details for China Medical System Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 867
What kind of share is China Medical System Holdings?
Based on an overall assessment of its quality, value and momentum China Medical System Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a China Medical System Holdings share price forecast for 2025?
The analyst consensus target price for shares in China Medical System Holdings is HK$10.76. That is 46.41% above the last closing price of HK$7.35.
Analysts covering China Medical System Holdings currently have a consensus Earnings Per Share (EPS) forecast of CNY0.68 for the next financial year.
Find out moreWhat is the trend in the China Medical System Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like China Medical System Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -8.11%.
As of the last closing price of HK$7.35, shares in China Medical System Holdings were trading -2.33% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the China Medical System Holdings PE Ratio?
The China Medical System Holdings PE ratio based on its reported earnings over the past 12 months is 9.61. The shares last closed at HK$7.35.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of China Medical System Holdings?
China Medical System Holdings' management team is headed by:
- Kong Lam - CHM
- Yanling Chen - CFO
- Hongbing Chen - COO
- Sanyan Wu - SEC
- Ching Fung - NID
- Chong Shun Leung - NID
- Laura Ying Luo - NID